Migraine headaches are one of the most common neurological disorders worldwide, affecting between 10–20% of the adult population. Migraines are caused by an interaction between environmental and genetic factors.
Genomic studies have dramatically increased our understanding of migraine pathophysiology. Evaluating a person’s genomic profile identifies susceptibility to developing migraines, and enables evidence-based, personalized prevention and treatment strategies.
The Complete Health and Ultimate Wellness genomic test panels evaluate areas related to migraines, including: Micronutrients, Renin-Angiotensin, Neuropeptides